diafyt MedTech Company
We develop smart devices and AI software to automate diabetes management. Just call it autonomous driving for diabetics. Insulin dosing is complicated and an important concern for people with diabetes. Incorrect dosing leads to organ failure and death. No easy way exists to calculate the optimal doses. diafyt AI learns the individual insulin demand of a type 1 diabetic in one week. So people live longer while being diabetic, save money on medicine and doctor visits and have less hassle every single day. Diafyt Guide has a medical device certification for Europe. https://play.google.com/store/apps/details?id=com.diafyt.guide&gl=DE
Industry:
AI
Headquarters:
Leipzig, Sachsen, Germany
Zip:
11-50
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
Seed
Acquisitions Number:
1
Investors Number:
683020
Total Funding:
683020
Last Funding Date:
Seed
Last Funding Type:
Thomas@diafyt.com
Register and Claim Ownership